BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 21040448)

  • 1. The platelet contribution to cancer progression.
    Bambace NM; Holmes CE
    J Thromb Haemost; 2011 Feb; 9(2):237-49. PubMed ID: 21040448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet function: does it offer a chance of better cancer progression control?
    Sierko E; Wojtukiewicz MZ
    Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and antiplatelet treatments in cancer.
    Tao DL; Tassi Yunga S; Williams CD; McCarty OJT
    Blood; 2021 Jun; 137(23):3201-3211. PubMed ID: 33940597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets in cancer. From basic research to therapeutic implications.
    Mammadova-Bach E; Mangin P; Lanza F; Gachet C
    Hamostaseologie; 2015; 35(4):325-36. PubMed ID: 26289826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?
    Wojtukiewicz MZ; Hempel D; Sierko E; Tucker SC; Honn KV
    Cancer Metastasis Rev; 2017 Jun; 36(2):305-329. PubMed ID: 28752248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer.
    Sharma D; Brummel-Ziedins KE; Bouchard BA; Holmes CE
    J Cell Physiol; 2014 Aug; 229(8):1005-15. PubMed ID: 24374897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The platelet-cancer loop.
    Goubran HA; Burnouf T; Radosevic M; El-Ekiaby M
    Eur J Intern Med; 2013 Jul; 24(5):393-400. PubMed ID: 23433737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents.
    Xu XR; Yousef GM; Ni H
    Blood; 2018 Apr; 131(16):1777-1789. PubMed ID: 29519806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of platelets in tumor cell metastasis.
    Tesfamariam B
    Pharmacol Ther; 2016 Jan; 157():112-9. PubMed ID: 26615781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
    Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
    Front Immunol; 2021; 12():807600. PubMed ID: 34987523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets and angiogenesis in malignancy.
    Sierko E; Wojtukiewicz MZ
    Semin Thromb Hemost; 2004 Feb; 30(1):95-108. PubMed ID: 15034801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction.
    Becker RC
    Arch Pathol Lab Med; 1993 Jan; 117(1):89-96. PubMed ID: 8418769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.
    Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H
    Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets: linking hemostasis and cancer.
    Jain S; Harris J; Ware J
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2362-7. PubMed ID: 21071699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subpopulations in purified platelets adhering on glass.
    Donati A; Gupta S; Reviakine I
    Biointerphases; 2016 Jun; 11(2):029811. PubMed ID: 27338300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences.
    Mezouar S; Frère C; Darbousset R; Mege D; Crescence L; Dignat-George F; Panicot-Dubois L; Dubois C
    Thromb Res; 2016 Mar; 139():65-76. PubMed ID: 26916298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
    French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
    J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein VI - novel target in antiplatelet medication.
    Borst O; Gawaz M
    Pharmacol Ther; 2021 Jan; 217():107630. PubMed ID: 32681846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current state and novel approaches of antiplatelet therapy.
    Metharom P; Berndt MC; Baker RI; Andrews RK
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1327-38. PubMed ID: 25838432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation in atherogenesis associated with low-grade inflammation.
    Antoniades C; Bakogiannis C; Tousoulis D; Demosthenous M; Marinou K; Stefanadis C
    Inflamm Allergy Drug Targets; 2010 Dec; 9(5):334-45. PubMed ID: 20632958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.